Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAXITAMAB-GQGK: 152 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
152
Total FAERS Reports
2 (1.3%)
Deaths Reported
56
Hospitalizations
152
As Primary/Secondary Suspect
17
Life-Threatening
1
Disabilities
Prescription
Status

FDA Application: 761171 ·

First Report: 20200101 · Latest Report: 20250715

What Are the Most Common NAXITAMAB-GQGK Side Effects?

#1 Most Reported
Hypotension
58 reports (38.2%)
#2 Most Reported
Pain
53 reports (34.9%)
#3 Most Reported
Hypertension
29 reports (19.1%)

All NAXITAMAB-GQGK Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hypotension 58 38.2% 0 24
Pain 53 34.9% 0 21
Hypertension 29 19.1% 0 19
Rash 24 15.8% 0 12
Urticaria 21 13.8% 0 8
Oxygen saturation decreased 17 11.2% 0 8
Bronchospasm 14 9.2% 0 8
Off label use 14 9.2% 0 7
Hypoxia 13 8.6% 0 8
Tachycardia 13 8.6% 0 4
Abdominal pain 12 7.9% 0 2
Vomiting 11 7.2% 0 5
Anaphylactic reaction 10 6.6% 0 5
Dyspnoea 10 6.6% 0 1
Pyrexia 10 6.6% 0 4
Cough 9 5.9% 0 2
Hypersensitivity 8 5.3% 0 1
Anaphylactic shock 7 4.6% 0 1
Myelosuppression 7 4.6% 0 3
Blood pressure decreased 6 4.0% 0 0

Who Reports NAXITAMAB-GQGK Side Effects? Age & Gender Data

Gender: 53.4% female, 46.6% male. Average age: 7.5 years. Most reports from: US. View detailed demographics →

Is NAXITAMAB-GQGK Getting Safer? Reports by Year

YearReportsDeathsHosp.
2020 1 0 0
2021 46 0 19
2022 24 0 10
2023 5 0 5
2024 23 0 6
2025 9 1 6

View full timeline →

What Is NAXITAMAB-GQGK Used For?

IndicationReports
Neuroblastoma 100
Neuroblastoma recurrent 38
Product used for unknown indication 6

NAXITAMAB-GQGK vs Alternatives: Which Is Safer?

NAXITAMAB-GQGK vs NEBIVOLOL NAXITAMAB-GQGK vs NECITUMUMAB NAXITAMAB-GQGK vs NEDAPLATIN NAXITAMAB-GQGK vs NEFAZODONE NAXITAMAB-GQGK vs NEFOPAM NAXITAMAB-GQGK vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG NAXITAMAB-GQGK vs NELARABINE NAXITAMAB-GQGK vs NELFINAVIR NAXITAMAB-GQGK vs NELVUTAMIG NAXITAMAB-GQGK vs NEMOLIZUMAB

Official FDA Label for NAXITAMAB-GQGK

Official prescribing information from the FDA-approved drug label.